Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer

Clinical and Experimental Medicine

Volumn 9, Issue 1, 2009, Pages 21-28

  Grando, João Paulo Souto ^a,b   Kuasne, Hellen ^a   Losi Guembarovski, Roberta ^a   Rodrigues, Iara Sant'ana ^a   Matsuda, Henrique Mitsu ^a   Fuganti, Paulo Emílio ^b   Gregório, Émerson Pereira ^b   Libos Jr , Farid ^a   De Menezes, Rodrigo Paes ^a   De Freitas Rodrigues, Marco Aurélio ^a   De Syllos Cólus, Ilce Mara ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b Hospital do Câncer de Londrina   (Brazil)

Author keywords

Bladder cancer; CYP1A1; GSTM1; GSTP1; GSTT1; Susceptibility genes

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

AGED; ARTICLE; BLADDER TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; URINARY BLADDER NEOPLASMS;

EID: 66449096552     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-008-0015-z     Document Type: Article

References (55)

1. Greenlee RT, Murray T, Bolden S, Wings PA (2000) Cancer statistics. CA Cancer J Clin 50(1):7
2. Johansson SL, Cohen SM (1997) Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13:291-298 (Pubitemid 27332851)
3. Zeegers MPA, Tan FES, Dorant E, Van den Brandt P (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk. A meta-analysis of epidemiologic studies. Cancer 89(3):630-639 (Pubitemid 30640110)
4. Hecht EM (2003) Tobacco carcinogens, their biomarkers and tobacco induced cancer. Nat Rev Cancer 3:733-744
5. Luch A (2005) Nature and nurture-lessons from chemical carcinogenesis. Nat Rev Cancer 5:113-125
6. Boffetta P, Jourenkova N, Gustavsson P (1997) Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444-472 (Pubitemid 27297808)
7. Yu MC, Skipper PL, Tannenbaum SR, Chan KK, Ross RK (2002) Arylamine exposures and bladder cancer risk. Mutat Res 506-507:21-28 (Pubitemid 35286536)
8. Patrianakos CHD (1979) Chemical studies on tobacco smoke. LXIUV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 3:150-154
9. Ma Q, Lu AYH (2007) CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metab Dispos 35:1009-1016 (Pubitemid 46956419)
10. Shimada T (2006) Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21:257-276
11. Song N, Tan W, Xing D, Lin D (2001) CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case control study in China. Carcinogenesis 22:11-16 (Pubitemid 32098138)
12. Sato M, Sato T, Izumo T, Amagasa T (1999) Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 20(10):1927-1931 (Pubitemid 29476118)
13. Sato M, Sato T, Izumo T, Amagasa T (2000) Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol 36:267-271 (Pubitemid 30227708)
14. Miller MC, Mohrenweiser HW, Bell DA (2001) Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120(1-3):269-280 (Pubitemid 32375093)
15. Their R, Brüning T, Roos PH, Hans-Peter Rihs PH, Golka K, Ko Y, Bolt HM (2003) Markers of genetics susceptibility in human environmental hygiene and toxicology: the role of selected CYP, Nat and GST genes. Int J Hyg Environ Health 206:149-171 (Pubitemid 36807091)
16. Salagovic J, Kalina I, Habalová V, Hrivnák M, Valanský L, Biros E (1999) The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res 48(6):465-471 (Pubitemid 30019556)
17. Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18(4):641-644 (Pubitemid 28132446)
18. Fryer AA, Ramsay HM, Lovatt TJ, Jones PW, Hawley CM, Nicol DL, Strange RC, Harden PN (2005) Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients. Carcinogenesis 26(1):185-191 (Pubitemid 40207714)
19. Gonlugur U, Pinarbasi H, Gonlugur TE, Silig Y (2006) The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome. Cancer Invest 24(5):497-501 (Pubitemid 44576402)
20. Little J, Sharp L, Masson LF, Brockton NT, Cotton SC, Haites NE, Cassidy J (2006) Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer 119(9):2155-2156
21. Saad AA, O'Connor PJ, Mostafa MH, Metwalli NE, Cooper DP, Povey AC, Margison GP (2005) Glutathione S-transferase M1, T1 and P1 polymorphisms and bladder cancer risk in Egyptians. Int J Biol Markers 20(1):69-72 (Pubitemid 40667603)
22. Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT (2005) Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a populationbased study. Cancer Lett 219(1):63-69 (Pubitemid 40203172)
23. Carrano AV, Natarajan AT (1988) Considerations for population monitoring using cytogenetic techniques. Mutat Res 204:379-406 (Pubitemid 18072333)
24. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extraction DNA from human nucleated cell. Nucleic Acid Res 16:1215
25. Abdel-Rahman SZ, El-Zein RA, Anwar WA, Au WW (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 107(2):229-233 (Pubitemid 26381994)
26. /-flanking region. Clin Investig 72:240-248 (Pubitemid 24103195)
27. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD (2005) Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48(2):339-344 (Pubitemid 40957115)
28. Jeong JH, Kim JH, Seo IY, Kim HJ, Oh GJ, Chae SC, Lim JS, Chung HT, Kim JJ (2003) Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett 202:193-199 (Pubitemid 37485892)
29. Pelucchi C, Bosetti C, Negri C, Malvezzi M, La Vecchia C (2006) Mechanisms of disease. The epidemiology of bladder cancer. Nat Clin Pract Urol 3(6):327-340 (Pubitemid 43871794)
30. Moore LE, Wiencke JK, Bates MN, Zheng S, Reym OA, Smith AH (2004) Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211(2):199-207 (Pubitemid 38824633)
31. Ryk C, Berggren P, Kuma R, Hemminki K, Larsson P, Steineck G, Lambert B, Hou SM (2005) Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours. Int J Cancer 113(5):761-768 (Pubitemid 40101257)
32. Salagovic J, Kalina I, Stubna J, Habalova V, Hrivnak M, Valansky L, Kohut A, Biros E (1998) Genetic polymorphism of glutathione S-transferase M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 45:312-317 (Pubitemid 29010681)
33. McGrath M, Michaud D, De Vivo L (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 6:239
34. Lin JH, Lu AY (1998) Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 35(5):361-390 (Pubitemid 28520008)
35. Kellen E, Zeegers M, Paulussen A, Vlietinck R, Vlem EV, Veulemans H, Buntinx F (2007) Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk. Cancer Lett 245(1-2):51-60 (Pubitemid 46001500)
36. Brockmöller J, Cascorbi I, Kerb R, Roots I (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915-3925 (Pubitemid 26284739)
37. Katoh T (1995) Application of molecular biology to occupational health field-the frequency of gene polymorphism of cytochrome P450 1A1 and glutathione S-transferase M1 in patients with lung, oral and urothelial cancer. J UOEH 17(4):271-278 (Pubitemid 26010816)
38. Daly AK, Thomas DJ, Cooper J, Pearson WR, Neal DE, Idle JR (1993) Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. BMJ 307(6902):481-482 (Pubitemid 23242103)
39. Mungan NA, Aben KKH, Beeks E, Kampman E, Bunschoten A, Bussemakers M, Witjes JA, Kiemeney LALM (2000) A germline homozygote deletion of the glutathione-S-transferase Mu1 gene predisposes to bladder cancer. Urol Int 64:134-138 (Pubitemid 30326599)
40. Arruda VR, Grignolli CE, Goncalves MS, Soares MC, Menezes R, Saad ST, Costa FF (1998) Prevalence of homozygosity for the deleted alleles of glutathione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: relevance to environmental carcinogenesis? Clin Genet 54(3):210-214 (Pubitemid 28425369)
41. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes MC, Pena SDJ (2003) Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100:177-182 (Pubitemid 36078048)
42. Brescia G, Celotti L, Clonfero E, Neumann HG, Forni A, Foà V, Pisoni M, Ferri GM, Assennato G (1999) The influence of cytochrome P450 1A1 and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers. J Arch Toxicol 73:8-9 431-439
43. Agundez JA (2004) Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5:211-224 (Pubitemid 38735776)
44. Katoh T, Inatomi H, Nagaoka A, Sugita A (1995) Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis 16:655-657
45. Houlston RS, Johns LE (2000) Glutathione S-transferase mu1(GSTM1) status and bladder cancer risk: a meta-analysis. Mutagenesis 15 (5):399-404
46. Nair U, Bartsch H (2001) Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Sci Publ 154:271-290
47. Quinones L, Lucas D, Godoy J, Caceres D, Berthou F, Varela N, Lee K, Acevedo C, Martinez L, Aguilera AM, Gil L (2001) CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35-44 (Pubitemid 33001306)
48. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun. Wee J, Kim WJ (2005) Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 65(1):70-75 (Pubitemid 40169608)
49. Brockmöller J, Kaiser R, Kerb R, Cascorbi I, Jaeger V, Roots I (1996) Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer. Pharmacogenetics 6:535-545
50. Carstensen U, Alexandrie AK, Hogstedt B, Rannug A, Bratt I, Hagmar L (1993) B-and T-lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1(class Mu). Mutat Res 289 (2):187-195 (Pubitemid 23287929)
51. Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156(1):68-73 (Pubitemid 39601062)
52. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U, Wijkstrom H, Larsson P, Kumar R, Hemminki K (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25(5):729-734 (Pubitemid 38618524)
53. Naccarati A, Soucek P, Stetina R, Haufroid V, Kumar R, Vodickova L, Trtkova K, Dusinska M, Hemminki K, Vodicka P (2006) Genetic polymorphisms and possible gene-gene interactions in metabolic and DNA repair genes: effects on DNA damage. Mutat Res 593(1-2):22-31 (Pubitemid 43113359)
54. Dörrenhaus A, Müller T, Roos PH (2007) Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers. Arch Toxicol 81:19-25 (Pubitemid 46115454)
55. Roos PH, Belik R, Föllmann W, Degen GH, Knopf HJ, Bolt HM, Golka K (2006) Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments. Arch Toxicol 80:45-52 (Pubitemid 41830994)